Production of peptide hormones and neurotransmitters by the immune system

Chemical Immunology

Volumn 69, Issue , 1997, Pages 1-30

  Weigent, Douglas A ^a   Blalock, J Edwin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS HORMONE; HYPOTHALAMUS RELEASING FACTOR; NEUROTRANSMITTER; PEPTIDE HORMONE;

HORMONE SYNTHESIS; IMMUNE SYSTEM; LEUKOCYTE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW;

EID: 0030701949     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058652     Document Type: Review

References (150)

1. Blalock JE, Smith EM: Human leukocyte interferon: Structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci USA 1980;77:5972-5974.
2. Smith EM, Blalock JE: Human lymphocyte production of corticotropin and endorphin-like substances: Association with leukocyte interferon. Proc Natl Acad Sci USA 1981;78:7530-7534.
3. Blalock JE, Smith EM: Human leukocyte interferon (HuIFN-alpha): Potent endorphin-like opioid activity. Biochem Biophys Res Commun 1981;101:472-478.
4. Harbour-McMenamin D, Smith EM, Blalock JE: Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infect Immun 1985;48:813-817.
5. Lolait SJ, Lim ATW, Toh BH, Funder JW: Immunoreactive β-endorphin in a subpopulation of mouse spleen macrophages. J Clin Invest 1984;73:277-280.
6. Endo Y, Sakata T, Watanabe S: Identification of proopiomelanocortin-producing cells in the rat pyloric antrum and duodenum by in situ mRNA-cDNA hybridization. Biomed Res 1985;6:253-256.
7. Farooqui JZ, Medrano EE, Boissy RE, Tigelaar RE, Nordlund JJ: Thy-1 + dendritic cells express truncated form of POMC mRNA. Exp Dermatol 1995;4:297-301.
8. Herbert E: Discovery of pro-opiomelanocortin: A cellular polyprotein. Trends Biochem Sci 1981; 6:184-186.
9. Blalock JE, Smith EM: A complete regulatory loop between the immune and neuroendocrine systems. Fed Proc 1985;44:108-111.
10. Smith EM, Meyer WJ, Blalock JE: Virus-induced corticosterone in hypophysectomized mice: A possible lymphoid adrenal axis. Science 1982;218:1311-1312.
11. Westly HJ, Kleiss AJ, Kelley KW, Wong PKY, Yuen PH: Newcastle disease virus-infected splenocytes express the pro-opiomelanocortin gene. J Exp Med 1986;163:1589-1594.
12. Lolait SJ, Clements JA, Markwick AJ, Cheng C, McNally M, Smith AI, Funder JW: Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J Clin Invest 1986;77:1776-1779.
13. Oates EL, Allaway GP, Armstrong GR, Boyajian RA, Kehr JH, Probhakar BS: Human lymphocytes produce pro-opiomelanocortin gene-related transcripts: Effects of lymphotropic viruses. J Biol Chem 1988;263:10041-10044.
14. Buzzetti R, McLoughlin L, Lavender PM, Clark AJ, Rees LH: Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 1989;83:733-737.
15. Smith EM, Galin FS, LeBoueuf RD, Coppenhaver DH, Harbour DV, Blalock JE: Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: Endotoxin induction of a truncated peptide. Proc Natl Acad Sci USA 1990;87:1057-1060.
16. Galin FS, LeBoueuf RD, Blalock JE: A lymphocyte mRNA encodes the adrenocorticotropin/β-lipotropin region of the pro-opiomelanocortin gene. Prog NeuroEndocrinImmunol 1990;3:205.
17. Galin FS, LeBoueuf RD, Blalock JE: Corticotropin-releasing factor upregulates expression of two truncated pro-opiomelanocortin transcripts in murine lymphocytes. J Neuroimmunol 1991;31:51-58.
18. Lyons PD, Blalock JE: Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunol 1997, in press.
19. Zurawski G, Benedik M, Kamb BJ, Abrams JS, Zurawski SM, Lee FD: Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 1986;232:772-775.
20. Kuis W, Villiger PM, Leser HG, Lotz M: Differential processing of proenkephalin-A by human peripheral blood monocytes and T lymphocytes. J Clin Invest 1991;88:817-824.
21. Kamphuis S, Kavelaars A, Brooimans R, Kuis W, Zegers BJM, Heijnen CJ: T helper 2 cytokines induce preproenkephalin mRNA expression and proenkephalin A in human peripheral blood mononuclear cells. J Neuroimmunol 1997;in press.
22. Smith EM, Phan M, Kruger TE, Coppenhaver DH, Blalock JE: Human lymphocyte production of immunoreactive thyrotropin. Proc Natl Acad Sci USA 1983;80:6010-6013.
23. Harbour DV, Kruger TE, Coppenhaver D, Smith EM, Meyer WJ 3d: Differential expression and regulation of thyrotropin (TSH) in T cell lines. Mol Cell Endocrinol 1989;64:229-241.
24. Kruger TE, Smith LR, Harbour DV, Blalock JE: Thyrotropin: An endogenous regulator of the in vitro immune response. J Immunol 1989;142:744-747.
25. Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C: Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci USA 1986;83:2599-2603.
26. Montgomery DW, Zukowski CF, Shah NG, Buckley AR, Pacholczyk T, Russell DH: Concanavalin A-stimulated murine leukocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Biophys Res Commun 1987;145:692-698.
27. Kenner JR, Holaday JW, Bernton EW, Smith PF: Prolactin-like protein in murine lymphocytes: Morphological and biochemical evidence. Prog NeuroEndocrinImmunol 1990;3:188-199.
28. DiMattia GE, Gellersen B, Bohnet HG, Friesen HG: A human β-lymphoblastoid cell line produces prolactin. Endocrinology 1988;122:2508-2517.
29. DiMattia GE, Gellersen B, Duckworth ML, Friesen HG: Human prolactin gene expression: The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. J Biol Chem 1990;2165:16412.
30. Friesen HG, DiMattia GE, Too CKL: Lymphoid tumor cells as models for studies of prolactin gene regulation and action. Prog NeuroEndocrinImmunol 1991;4:1-9.
31. Clevenger CV, Russell DH, Appasamy PM, Prystowsky MB: Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci USA 1990;87:6460-6464.
32. Jurcovicova J, Day RN, MacLeod RM: Expression of prolactin in rat lymphocytes. Prog NeuroEndocrinImmunol 1992;2:256-263.
33. Pellegrini I, Lebrun J-I, Ali S, Kelly PA: Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992;6:1023-1031.
34. O'Neal KD, Montgomery DW, Truong TM, Yu-Lee L-Y: Prolactin gene expression in human thymocytes. Mol Cell Endocrinol 1992;87:R19-R23.
35. Montgomery DW, Shen GK, Ulrich ED, Steiner LL, Parrish PR, Zukoski CF: Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like protein. Endocrinology 1992;131:3019-3026.
36. Harbour-McMenamin D, Smith EM, Blalock JE: Production of immunoreactive chorionic gonadotropin during mixed lymphocyte reactions: A possible selective mechanism for genetic diversity. Proc Natl Acad Sci USA 1986;83:6834-6838.
37. Batanero E, deLeeuw FE, Jansen GH, vanWichen DF, Huber J, Schuurman HJ: The neural and neuro-endocrine component of the human thymus. II. Hormone immunoreactivity. Brain Behav Immun 1992;6:249-264.
38. Ebaugh MJ, Smith EM: Human lymphocyte production of immunoreactive luteinizing hormone (abstract). FASEB J 1988;2:7811.
39. Smith EM, Ebaugh MJ: Luteogenic activity from human leukocytes. Ann NY Acad Sci 1990;594: 492-493.
40. Blalock JE, Costa O: Immune neuroendocrine interactions: Implications for reproductive physiology. Ann NY Acad Sci 1989;564:261-266.
41. Costa O, Mulchahey JJ, Blalock JE: Structure and function of luteinizing hormone releasing hormone (LHRH) receptors on lymphocytes. Prog NeuroEndocrinImmunol 1990;3:55-60.
42. Maier RM, Chew BP: Stimulation of progesterone secretion by blood monocytes and lymphocytes in the porcine. Theriogenology 1989;33:1045-1056.
43. Standaert FE, Chew BP, Wong TS: Influence of blood monocytes and lymphocytes on progesterone production by granulosa cells from smalll and large follicles in the pig. Am J Reprod Immunol 1990;22:49-55.
44. Standaert FE, Chew BP, Wong TS, Michal JJ: Porcine lymphocytes secrete factors in response to LHRH to stimulate progesterone production by granulosa cells in vitro (abstract). Biol Reprod 1990;42:75.
45. Gorospe WC, Kasson BG: Lymphokines from concanavalin-A-slimulated lymphocytes regulate rat granulosa cell steroidogenesis in vitro. Endocrinology 1989;123:2462-2471.
46. Kasson BG, Tuchel TL: Identification and characterization of a lymphocyte-produced substance with gonadotropin-like activity (abstract). Endocrinology 1989;75.
47. Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL, Blalock JE: Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 1988;2:2812-2818.
48. Guarcello V, Weigent DA, Blalock JE: Growth hormone releasing hormone receptors on thymocytes and splenocytes from rats. Cell Immunol 1991;136:291-302.
49. Hattori N, Shimatsu A, Sugita M, Kumagai S, Imura H: Immunoreactive growth hormone (GH) secretion by human lymphocytes: Augmented release by exogenous GH. Biochem Biophys Res Commun 1990;168:396-401.
50. Weigent DA, Blalock JE: The production of growth hormone by subpopulations of rat mononuclear leukocytes. Cell Immunol 1991;135:55-65.
51. Kao TL, Harbour DV, Meyer WJ 3d: Immunoreactive growth hormone production by cultured lymphocytes. Ann NY Acad Sci 1992;650:179-181.
52. Lytras A, Quan N, Vrontakis ME, Shaw JE, Cattini PA, Friesen HG: Growth hormone expression in human Burkitt lymphoma serum-free Ramos cell line. Endocrinology 1993;132:620-628.
53. Varma S, Sabharwal P, Sheridan JF, Malarkey WB: Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J Clin Endocrinol Metab 1993;76:49-53.
54. Weigent DA, Blalock JE: Associations between the neuroendocrine and immune systems. J Leukocyte Biol 1995;58:137-150.
55. Rohn WA, Weigent DA: Cloning and nucleotide sequencing of rat lymphocyte growth hormone cDNA. Neuroimmunomodulation 1995;2:108-114.
56. Stephanou A, Jessop DS, Knight RA, Lightman SL: Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav Immun 1990;4:67-73.
57. Aird F, Clevenger CV, Prystowsky MB, Redei E: Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc Natl Acad Sci USA 1993;90:7104-7108.
58. Ekman R, Servenius B, Castro MG, Lowry PJ, Cederlund AS, Bergman O, Sjogren HO: Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J Neuroimmunol 1993;44:7-13.
59. Kravchenco IV, Furalev VA: Secretion of immunoreactive CRF and ACTH by T- and B-lymphocytes in response to cellular stress factors. Biochem Biophys Res Commun 1994.204:828-834.
60. Emanuele NV, Emanuele MA, Tentler J, Kirsteins L, Azad N, Lawrence AM: Rat spleen lymphocytes contain an immunoactive and bioactive luteinizing hormone-releasing hormone. Endocrinology 1990;126:2482-2486.
61. Azad N, Emanuelle NV, Halloran MM, Tentler J, Kelley MR: Presence of luteinizing hormone-releasing hormone (LHRH) mRNA in spleen lymphocytes. Endocrinology 1992;128:1679-1681.
62. Maier CC, Marchetti B, LeBoeuf RD, Blalock JE: Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. Cell Mol Neurobiol 1992;12: 447-454.
63. Wilson TM, Yu-Lee L, Kelley MR: Coordinate gene expression of luteinizing hormone-releasing hormone (LHRH) and the LHRH-receptor after prolactin stimulation in the rat Nb2 T-cell line: Implications for a role in immunomodulation and cell cycle gene expression. Mol Endocrinol 1995; 9:44-53.
64. Weigent DA, Blalock JE: Immunoreactive growth hormone-releasing hormone in rat leukocytes. J Neuroimmunol 1990;29:1-13.
65. Weigent DA, Riley JE, Galin FS, LeBoeuf RD, Blalock JE: Detection of growth hormone and growth hormone-releasing hormone-related messenger RNA in rat leukocytes by the polymerase chain reaction. Proc Soc Exp Biol Med 1991;198:643-648.
66. Smith EM, Morrill AC, Meyer WJ 3d, Blalock JE: Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 1986;321:881-882.
67. Cutz E, Chan W, Track N, Goth A, Said S: Release of vasoactive intestinal peptide in mast cells by histamine liberators. Nature 1978;275:661-662.
68. Giachetti A, Goth A, Said SI: Vasoactive intestinal polypeptide (VIP) in rabbit platelets, and rat mast cells. Fed Proc 1978;37:657.
69. Goetzl EJ, Grotmol T, Van Dyke RW, Turck CW, Wershil B, Galli SJ, Sreedharan SP: Generation and recognition of vasoactive intestinal peptide by cells of the immune system. Ann NY Acad Sci 1990;594:34-44.
70. Lygren I, Revhaug A, Burhol PG, Giercksky E, Jenssen TG: Vasoactive intestinal peptide and somatostatin in leukocytes. Scand J Clin Lab Invest 1984;44:347-351.
71. O'Dorisio MS, O'Dorisio TM, Cataland S, Balcerzak SP: Vasoactive intestinal peptide as a biochemical marker for polymorphonuclear leukocytes. J Lab Clin Med 1980;96:666-670.
72. Aguila MC, Dees WL, Haensly WE, McCann SM: Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci USA 1991;88:11485-11489.
73. Aguila MC, Rodriguez AM, Aguila-Mansila HN, Lee WT: Somatostatin antisense oligodeoxynucleotide-mediated stimulation of lymphocyte proliferation in culture. Endocrinology 1996;137:1585-1590.
74. Ericsson A, Larhammar D, McIntyre KR, Persson H: A molecular genetic approach to the identification of genes expressed predominantly in the neuroendocrine and immune systems. Immunol Rev 1987;100:261-277.
75. Schwarz H, Villiger PM, von Kempis J, Lotz M: Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol 1994;51:53-61.
76. Pascual DW, Bost KL: Substance P production by P388D1 macrophages: A possible autocrine function for this neuropeptide. Immunology 1990;71:52-56.
77. Kelly PA, Blalock JE, Chrousos GP, Yu-Lee L-Y, Geenen V: Neuroendocrine hormones and the immune system; in Cuello AC, Collier B (eds): Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s. Basel, Birkhauser, 1995, pp 365-372.
78. Markwick AJ, Lolait SJ, Funder JW: Immunoreactive arginine vasopressin in the rat thymus. Endocrinology 1986;119:1690-1696.
79. Geenen V, Robert F, Martens H, Benhida A, De Giovanni G, Defresne MP, Boniver J, Legros JJ, Martial J, Franchimont P: Biosynthesis and paracrine/cryptocrine actions of 'self' neurohypophysial-related paptides in the thymus. Mol Cell Endocrin 1991;76:C27-31.
80. Jessop DS, Chowdrey HS, Lightman SL, Larsen PJ: Vasopressin is located within lymphocytes in the rat spleen. J Neuroimmunol 1995;56:219-223.
81. Adachi N, Yamaguchi K, Miyake Y, Honda S, Nagasaki K, Akiyama Y, Adachi I, Abe K: Parathyroid hormone-related protein is a possible autocrine growth inhibitor for lymphocytes. Biochem Biophys Res Commun 1990;166:1088-1094.
82. Fukumoto S, Matsumoto T, Watanabe T, Takhashi H, Miyoshi I, Ogata E: Secretion of parathyroid hormone-like activity from human T-cell lymphotropic virus type I-infected lymphocytes. Cancer Res 1989;49:3849-3852.
83. Rom WN, Basset P, Fells GA, Nukiwa T, Trapnell BC, Crystal RG: Alveolar macrophages release an insulin-like growth factor I-type molecule. J Clin Invest 1988;82:1685-1693.
84. Merimee TJ, Grant MB, Broder CM, Cavalli-Sforza LL: Insulin-like growth factor secretion by human B-lymphocytes: A comparison of cells from normal and pygmy subjects. J Clin Endocrinol Metab 1989;69:978-984.
85. Baxter JB, Blalock JE, Weigent DA: Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology 1991;129:1727-1734.
86. Arkins S, Rebeiz N, Biragyn A, Reese DL, Kelley KW: M urine macrophages express abundant IGF-I class I, Ea and Eb transcripts. Endocrinology 1993;133:2334-2343.
87. Li YM, Arkins S, McCusker RH Jr, Donovan SM, Liu Q, Jayaraman S, Dantzer R, Kelley KW: Macrophages synthesize and secrete a 25 KDa protein that binds insulin-like growth factor-I. J Immunol 1996;156:64-72.
88. Funk JL, Lausier J, Moser AH, Shigenaga JK, Huling S, Nissenson RA, Strewler GJ, Grunfeld C, Feingold KR: Endotoxin induces parathyroid hormone-related protein gene expression in splenic stromal and smooth muscle cells, not in splenic lymphocytes. Endocrinology 1995;136:3412-3422.
89. Nyman T, Pekonen F: The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol 1993;128:168-172.
90. LeBoeuf RD, Burns JN, Bost KL, Blalock JE: Isolation, purification, and partial characterization of suppressin, a novel inhibitor of cell proliferation. J Biol Chem 1990;265:158-165.
91. LeBoeuf RD, Carr DJJ, Green MM, Blalock JE: Cellular effects of suppressin: A biological response modifier of cells of the immune system. Proc NeuroEndocrinImmunol 1990;3:176-187.
92. Carr DJ, Blalock JE, Green MM, LeBoeuf RD: Immunomodulatory characteristics of a novel antiproliferative protein, suppressin. J Neuroimmunol 1990;30:179-187.
93. Ban EM, Propst SM, Blalock JE, LeBoeuf RD: Identification of suppressin-producing cells in the rat pituitary. Endocrinology 1993;133:241-247.
94. Ban EMH, LeBoeuf RD: Suppressin: An endogenous negative regulator of immune cell activation. Immunol Res 1995;13:1-9.
95. Ericsson A, Barbany G, Friedman WJ, Persson H: Molecular cloning and characterization of genes predominantly expressed in the neuroendocrine and immune systems. Prog NeuroEndocrinImmunol 1991;4:26-11.
96. Ericsson A, Barbany G, Persson H: Regional and temporal distribution of the neuroimmune mRNA NI-1 in the rat central nervous system. Prog NeuroEndocrinImmunol 1991;4:42-55.
97. Musso NR, Brenci S, Setti M, Indiveri F, Lotti G: Catecholamie content and in vitro catecholamine synthesis in peripheral human lymphocytes. J Clin Endocrinol Metab 1996;81:1-5.
98. Sacerdote P, Ciciliato IA, Rubboli F, Panerai AE: Effects of psychoactive drugs on lymphocyte neuropeptides. Ann NY Acad Sci 1990;594:270-279.
99. Kavelaars A, Berkenbosch F, Croiset G, Ballieux RE, Heijnen CJ: Induction of beta-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 1990;126:759-764.
100. Kavelaars A, Ballieux RE, Heijnen CJ: The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells. J Immunol 1989;142:2338-2342.
101. Schettini G: Interleukin-1 in the neuroendocrine system: From gene to function. Prog NeuroEndocrinImmunol 1990;3:157-166.
102. Blalock JE: The syntax of immune-neuroendocrine communication. Immunol Today 1994;15:504-511.
103. Payne LC, Weigent DA, Blalock JE: Induction of pituitary sensitivity to interleukin-1: A new function for corticotropin-releasing hormone. Biochem Biophys Res Commun 1994;198:480-484.
104. Kavelaars A, Ballieux RE, Heijnen CJ: Beta-endorphin secretionby human peripheral blood mononuclear cells: Regulation by glucocorticoids. Life Sci 1990;46:1233-1240.
105. Buzzetti R, Valente L, Barietta C, Scavo D, Pozzilli P: Thymopentin induces release of ACTH-like immunoreactivity by human lymphocytes. J Clin Lab Immunol 1989;29:157-159.
106. Clarke BL, Gebhardt BM, Blalock JE: Mitogen-stimulated lymphocytes release biologically active corticotropin. Endocrinology 1993;132:983-988.
107. Gellersen B, DiMattia GE, Friesen HG, Bohnet HG: Phorbol ester stimulates prolactin release but reduces prolactin mRNA in the human β-lymphoblastoid cell line IM-9-P. Mol Cell Endocrinol 1989;66:153-161.
108. Gellersen B, DiMattia GE, Friesen HG, Bohnet HG: Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion. Enddocrinology 1989;125:2853-2861.
109. Gellersen B, Kempf R, Hartung S, Bonhoff A, DiMattia GE: Posttranscriptional regulation of the human prolactin gene in IM-9-P3 cells by retinoic acid. Endocrinology 1992;131:1017-1025.
110. Gellersen B, Kempf R, Telgmann R, DiMattia GE: Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 1994;8:356-373.
111. Hattori N, Shimormura K, Ishihara T, Moridera K, Hino M, Ikekubo K, Kurahachi H: Growth hormone (GH) secretion from human lymphocytes is up-regulated by GH, but not affected by insulin-like growth factor-1. J Clin Endocinol Metab 1993;76:937-939.
112. Kao TL, Meyer WJ: Inhibition of immunoreactive growth hormone secretion from lymphoid cell lines by dexamethasone. Life Sci 1992;51:1033-1039.
113. Weigent DA, Blalock JE: Growth hormone and the immune system. Prog NeuroEndocrinImmunol 1990;3:231-241.
114. Weigent DA, Blalock JE: Effect of the administration of growth hormone-producing lymphocytes on weight gain and immune function in dwarf mice. Neuroimmunomodulation 1994;1:50-58.
115. Azad N, LaPaglia N, Jurgens KAJ, Kirsteins L, Emanuele NV, Kelley MR, Lawrence AM, Mohagheghpour N: Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T-lymphocytes. Endocrinology 1996; 133:215-223.
116. Mohagheghpour N, Abel K, LaPaglia N, Emanuele NV, Azad N: Signal requirements for production of luteinizing hormone releasing-hormone by human T cells. Cell Immunol 1995;163:280-283.
117. Krieger DT: Brain peptides. Science 1983;222:975-985.
118. Loh YP, Parish DC, Tuteja R: Purification and characterization of a paired basic residue-specific pro-opiomelanocortin converting enzyme from bovine pituitary intermediate lobe secretory vesicles. J Biol Chem 1985;260:7194-7205.
119. Cromlish JA, Seidah NG, Chretein M: Selective cleavage of human ACTH beta-lipotropin, and the N-terminal glycopeptide at pairs of basic residues by IRCM-serine protease. I. Subcellular localization in small and large vesicles. J Biol Chem 1986;261:10857-10859.
120. Harbour-McMenamin D, Smith EM, Blalock JE: B lymphocyte-enriched populations produce immunoreactive endorphin that binds to delta opiate receptors and may play a role in endotoxic shock. ICSU short reports. Adv Gene Technol 1986;4:378-379.
121. Star RA, Rajora N, Huang J, Stock RC, Cattania A, Lipton JM: Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 1995;92:8016-8020.
122. Rajora N, Ceriani G, Catania A, Star RA, Murphy MT, Lipton JM: Alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leuk Biol 1996; 59:248-253.
123. Harbour DV, Smith EM, Blalock JE: Novel processing pathway for proopiomelanocortin in lymphocytes: Endotoxin induction of a new prohormone-cleaving enzyme. J Neurosci Res 1987; 18:95-101.
124. Johnson HM, Smith EM, Torres BA, Blalock JE: Neuroendocrine hormone regulation of in vitro antibody formation. Proc Natl Acad Sci USA 1982;79:4171-4174.
125. Gilman SC, Schwartz JM, Milnher RJ, Bloom FE, Feldman JD: β-Endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci USA 1982;79:4226-4230.
126. Wenger GD, O'Dorisio MS, Goetzl EJ: Vasoactive intestinal peptide: Messenger in a neuroimmune axis. Ann NY Acad Sci 1990;594:104-119.
127. Blalock JE: The immune system as a sensory organ. J Immunol 1984;132:1067-1070.
128. Lyons PD, Blalock JE: The kinetics of ACTH expression in rat leukocyte subpopulations. J Neuroimmunol 1995;63:103-112.
129. Kruger TE, Blalock JE: Cellular requirements for thyrotropin enhancement of in vitro antibody production. J Immunol 1986;137:197-200.
130. Wu H, Devi R, Malarkey WB: Expression and localization of prolactin messenger ribonucleic acid in the human immune system. Endocrinology 1996;137:349-353.
131. Gomariz RP, Leceta J, Garrido E, Garrido T, Delgado M: Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes. Regul Pept 1994;50:177-184.
132. Blalock JE, Johnson HM, Smith EM, Torres BA: Enhancement of the in vitro antibody response by thyrotropin. Biochem Biophys Res Commun 1984;125:30-34.
133. Hartmann DP, Holaday JW, Bernton EW: Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 1989;3:2194-2202.
134. Carr DJ, DeCosta BR, Jacobson AE, Rice KC, Blalock JE: Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway. J Neuroimmunol 1990; 28:53-61.
135. Weigent DA, Blalock JE, LeBoeuf RD: An antisense oligodeoxynucleotide Io growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. Endocrinology 1991;128:2053-2057.
136. Payne LC, Rohn W, Weigent DA: Lymphocyte-derived growth hormone releasing hormone is an autocrine modulator of lymphocyte-derived growth hormone (abstract). Endocrinology 1994;A1255: 514.
137. Weigent DA, Baxter JB, Blalock JE: The production of growth hormone and insulin-like growth factor-I by the same subpopulation of rat mononuclear leukocytes. Brain Behav Immun 1992;6: 365-376.
138. Dunn AJ, Powell ML, Gaskin JM: Virus-induced increases in plasma corticosterone. Science 1987; 238:1423-1425.
139. Olsen NJ, Nicholson WE, DeBold CR, Orth DN: Lymphocyte-derived adrenocorticotropin is insufficient to stimulate adrenal steroidogenesis in hypophysectomized rats. Endocrinology 1992;130: 2113-2119.
140. Bayle JE, Guellati M, Ibos F, Roux J: Brucella abortus antigen stimulates the pituitary-adrenal axis through the extra-pituitary B-lymphoid system. Prog NeuroEndocrinImmunol 1991;4:99-105.
141. Meyer WJ, Smith EM, Richards GE, Cavallo A, Morrill AC, Blalock JE: In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-deficient individuals. J Clin Endocrinol Metab 1987;64:98-105.
142. Van Wyk JJ, Dugger GS, Newsome JF, Thomas PZ: The effect of pituitary stalk section in the adrenal function of women with cancer of the breast. J Clin Endocrinol Metab 1960;20:157-172.
143. Fehm HL, Holl R, Spath-Schwalbe E, Voigt KH, Born J: Ability of human corticotropin releasing factor (hCRF) to stimulate cortisol secretion independent from pituitary ACTH. Life Sci 1988;42: 679-686.
144. Reynolds DG, Gurll NJ, Vargish T, Lechner RB, Faden AI, Holaday JW: Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock. Circul Shock 1980;7:39-48.
145. Carr DB, Bergland R, Hamilton A, Blume H, Kasting N, Arnold M, Martin MB, Rosenblatt M: Endotoxin-stimulated opioid peptide secretion: Two secretory pools and feedback control in vivo. Science 1982;217:845-848.
146. Bohs CT, Fish JC, Miller TH, Traber DL: Pulmonary vascular response to endotoxin in normal and lymphocyte depleted sheep. Circ Shock 1979;6:13-21.
147. Harbour DV, Smith EM, Blalock JE: Splenic lymphocyte production of an endorphin during endotoxic shock. Brain Behav Immun 1987;1:123-133.
148. Stein C, Hassan AHS, Przewlocki R, Gramsch C, Peter K, Herz A: Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990;87:5935-5939.
149. Schafer M, Mousa SA, Zhang Q, Carter L, Stein C: Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA 1996;93:6096-6100.
150. Sabharwal P, Varma S, Malarkey WB: Human thymocytes secrete luteinizing hormone: An autocrine regulator of T-cell proliferation. Biochem Biophys Res Commun 1992;187:1187-1192.